logo
Plus   Neg
Share
Email

Roche Announces First Approval For Tecentriq-based Therapy In China

Roche (RHHBY) said the China National Medical Products Administration has approved Tecentriq in combination with chemotherapy for the first-line treatment of patients with extensive-stage small cell lung cancer. The company noted that approval in China comes less than a year after the FDA and EMA approvals in the indication.

In January 2020, the China National Medical Products Administration also accepted the supplemental Biologics License Application for Tecentriq in combination with Avastin for the treatment of people with unresectable hepatocellular carcinoma.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Brooklyn, New York-based H&C Food Inc. is recalling select Enoki mushrooms citing the possible presence of Listeria monocytogenes, the U.S. Food and Drug Administration said in a statement. The recall involves 7.05 oz or 200G pack of Enoki mushrooms imported from Green Co. located in Korea. The affected Enoki mushrooms were distributed to New York, Maryland and Virginia areas. Tesla Inc. is planning to cut pays and furlough non-essential workers as the shut down of its vehicle production continues amid escalating coronavirus or Covid-19 cases. As per multiple reports citing an e-mail sent to all employees by North American HR Valerie Capers, the luxury electric car maker is taking certain actions starting April 13, aiming to manage costs. Facebook said it is launching new tools that will help health researchers to track and combat the spread of COVID-19 by using anonymized location data from users. The social media giant said its 'Data for Good' program is developing Disease Prevention Maps that provide details on how population movements around regions are influencing the spread of the disease.
Follow RTT
>